UAE Pacemaker Market, By Type (Implantable v/s External), By Technology (Single Chamber, Dual Chamber, Biventricular Chamber), By Product Type (Conventional v/s MRI Compatible), By Application (Arrythmias, Congestive Heart Failure, Others), By End User (H

UAE Pacemaker Market, By Type (Implantable v/s External), By Technology (Single Chamber, Dual Chamber, Biventricular Chamber), By Product Type (Conventional v/s MRI Compatible), By Application (Arrythmias, Congestive Heart Failure, Others), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers), By Region, Competition Forecast & Opportunities, 2027

UAE pacemaker market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of the growing number of heart surgeries. Open heart surgeries were performed to establish an artificial medical device that functions to filter the blood in the system thus driving the growth of the UAE pacemaker market in the upcoming five years. Growing demands for technologically advanced medical devices and a surge in the demand to increase the availability of fine healthcare services further aid the import of such medical devices and support the growth of the UAE pacemaker market in the next five years.

A cardiac pacemaker is a medical device that generates electrical impulses delivered by the electrodes to cause the heart muscle chambers to contract and therefore pump blood. The device replaces or regulates the function of the electrical conduction system of the heart. Pacemakers require patients suffering from various heart diseases like tachycardia, bradycardia, irregular heartbeat, abnormal heart palpitation, etc.

Growing Disease Burden Drives Market Growth

Increasing instances of chronic diseases like cardiovascular diseases and kidney failures actively drive the growth of the UAE pacemaker market in the upcoming five years. In the United Arab Emirates (UAE), CVD contributes to 40% of all deaths and its incidence is increasing in young adults mainly because of an increase in the burden of its known risk factors such as abdominal obesity (71.5%), dyslipidemia (74.0%), hypertension (43.0%), and diabetes (32.4%). These diseases cumulatively increase the chances of patients suffering from heart conditions. The situations are riskier among the geriatric population. The growing geriatric population and their tendency to suffer from cardiovascular diseases also aid in the growth of the UAE pacemaker market in the next five years.

Growing Investments In Healthcare Industry

A surge in the demand for technologically advanced medical devices and actively investing in the imports of the advanced medical device since research & development of innovative products is difficult is further aiding the growth of the UAE pacemaker market in the upcoming five years. Increasing investments in localized manufacturing to pause rapidly increasing expenses over the import of medical devices is also aiding the market growth indirectly. Advanced technologies like 3D printing are being employed. 3D printing in healthcare and exploiting the technology for manufacturing medical devices with the disclosure ‘Dubai 3D Printing Strategy’. Earlier this year, the Dubai Health Authority partnered with Sinterex, a startup specializing in medical 3D printing, to manufacture 3D printing labs and facilitate 3D printing to the point-of-care at DHA hospitals – Rashid, Latifa, Dubai, and Hatta Hospital.

Market Segmentation

The UAE pacemaker market is segmented by type, technology, product type, application, end-user, competitional landscape, and regional distribution. Based on type, the market is differentiated between implantable and external. By technology, the market is fragmented into a single chamber, dual chamber, and biventricular chamber. Based on product type, the market is divided between conventional and MRI-compatible. By application, the market is further segmented into arrhythmias, congestive heart failure, and others. Based on end users, the market is bifurcated into hospitals, cardiac care centers, and ambulatory surgical centers. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, rest of UAE.

Company Profile

Medtronic Meta FZ-LLC, Boston Scientific Corporation UAE, Abbott Laboratories, S.A., GE Healthcare UAE, and BIOTRONIK, UAE, among others is a partial list of major market players of the companies responsible for the growth of UAE pacemaker market.

Report Scope:

In this report, UAE pacemaker market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UAE Pacemaker Market, By Type:
• Implantable
• External
• UAE Pacemaker Market, By Technology:
• Single Chamber
• Dual Chamber
• Biventricular Chamber
• UAE Pacemaker Market, By Product Type:
• Conventional
• MRI Compatible
• UAE Pacemaker Market, By Application:
• Arrhythmias
• Congestive Heart Failure
• Others
• UAE Pacemaker Market, By End User:
• Hospitals
• Cardiac Care Centers
• Ambulatory Surgical Centers
• UAE Pacemaker Market, By Region:
• Abu Dhabi
• Dubai
• Sharjah
• Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE pacemaker market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights